Georgia Healthcare Group PLC (LON:GHG) had its price objective lowered by Berenberg Bank from GBX 504 ($6.63) to GBX 415 ($5.46) in a report published on Monday. The firm currently has a buy rating on the stock.

A number of other equities research analysts have also commented on the company. Jefferies Group LLC decreased their price target on Georgia Healthcare Group PLC from GBX 395 ($5.20) to GBX 370 ($4.87) and set a buy rating on the stock in a research report on Monday, September 25th. Numis Securities Ltd restated an add rating and set a GBX 420 ($5.52) price target on shares of Georgia Healthcare Group PLC in a research report on Tuesday, August 15th.

Shares of Georgia Healthcare Group PLC (LON GHG) opened at GBX 346.25 ($4.55) on Monday. Georgia Healthcare Group PLC has a 12-month low of GBX 290 ($3.81) and a 12-month high of GBX 403.50 ($5.31).

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at

Georgia Healthcare Group PLC Company Profile

Georgia Healthcare Group PLC is a United Kingdom-based holding company. The Company provides healthcare services in Georgian healthcare services market. The Company operates in two segments based on products and services: Healthcare services and Medical insurance. The Company’s Healthcare services are the inpatient and outpatient medical services delivered by the referral hospitals, community hospitals and ambulatory clinics owned by the Company throughout the Georgian territory.

Receive News & Stock Ratings for Georgia Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Georgia Healthcare Group PLC and related stocks with our FREE daily email newsletter.